In a May 7, 2024 press release, Seragon Biosciences announced that its aging intervention drug candidate, SRN-901, achieved one of the largest extensions of
Telomere attrition—gradual loss of chromosome caps—links to heart disease, immune decline, and frailty. Explore new data, lifestyle levers, and emerging therapies.
Staying socially active is the key to healthy aging, boosting brain health, reducing disease risk, and enhancing life satisfaction. Connection is longevity’s elixir.